This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Escitalopram in Obsessive-Compulsive Disorder: A Case Series

Amit Zutshi, MD; Suresh Bada Math, MD, DNB, PGDMLE; and Y. C. Janardhan Reddy, DPm, MD

Published: December 14, 2007

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Obsessive-compulsive disorder (OCD) is a chronic anddebilitating psychiatric disorder. The lifetime prevalence ofOCD is estimated to be 1.94% to 3.29% according to population-based surveys.1-3 Serotonin reuptake inhibitors (SRIs) areknown to be effective in OCD.4-6

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 9

Quick Links: